Jeffrey Stevens, the CEO and co-founder of Psyched Wellness PSYCF, has bought 321,000 shares of the company in the open market at CA$0.125 per share for a total cost of of CA$40,125 (around $31,750).
“Our stock price has increased in the last quarter alone. In addition to our market growth, we have experienced a number of recent successes that have strengthened our position and are excited to be approved to launch our flagship product, Calm, in the U.S.," Stevens said.
The psychedelics exec is speaking later Tuesday at the inaugural Benzinga Psychedelics Capital Conference.
"Our stock price doesn't reflect this growth yet, but it will. We have been working diligently to position and grow our business, and I believe that we are on track to deliver sustainable, long-term shareholder value.”
PSYCF Price Action: Psyched Wellness shares were trading 2.22% higher at $0.092 late Tuesday morning.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!